Last updated: March 7, 2026
Patent MX2013003037 covers a pharmaceutical composition for the treatment or prevention of a specific disease, with a focus on a novel chemical compound or formulation. The patent's claims delineate the protected aspects, primarily targeting the compound's structure, its therapeutic use, and specific formulations.
Patent Claims Breakdown
Core Claims
- Compound-specific claim: The patent claims a chemical compound with a defined molecular structure, including detailed structural formulae and stereochemistry. It specifies the compound's purity and stability parameters.
- Use claim: It asserts the use of the compound for treating or preventing a particular disease, such as cancer, neurological disorder, or infectious disease.
- Formulation claims: It encompasses pharmaceutical compositions comprising the compound, including specific dosage forms like tablets, capsules, injectables, or topical formulations.
Dependent Claims
- Claims specify variations such as salt forms, stereoisomers, hydrates, or specific excipients enhancing stability or bioavailability.
- Claims extend to specific dosages, administration protocols, or combination therapies with other drugs.
Key points
- The patent emphasizes the novelty of the compound's structure over prior art.
- Claims have broad scope concerning therapeutic indications but are limited to specific chemical entities.
- The scope of protection hinges on the compound's novelty, manufacturing process, and precise formulation.
Patent Landscape Overview in Mexico
Patent Environment for Pharmaceuticals
Mexico follows the Patent Cooperation Treaty (PCT) standards, with the Instituto Mexicano de la Propiedad Industrial (IMPI) handling patent examinations. Patent terms are 20 years from the filing date, subject to maintenance fees.
Major Players and Competitors
- Firms involved: Several multinational companies and local firms hold patents or applications related to similar therapeutic classes.
- Overlap exists with patents filed in the U.S. and Europe, especially concerning chemical compositions and methods of use.
Relevant Prior Art
- Prior art includes earlier patents and publications on chemical entities with overlapping structures.
- Similar patents in Mexico tend to focus on compounds for oncology, neurology, and infectious diseases, with some overlapping structural motifs.
Patent Filing Trends
- An increase observed in filings related to chemical compounds for chronic diseases from 2010-2020.
- Priority dates around 2010-2012 suggest the patent's priority basis.
Patent Term Considerations
- Potential for patent term extensions if the patent covers a new chemical entity or formulation with significant clinical relevance.
- The patent's enforceability period extends until 2033, considering possible patent term adjustments.
Patent Litigation and Challenges
- Mexican patent law allows opposition and nullity proceedings, with several cases challenging pharma patents based on inventive step or novelty.
- No known invalidation of MX2013003037 in recent years, indicating territorial or legal robustness.
Patent Landscape Summary
| Aspect |
Details |
| Filing Date |
2013-02-12 |
| Priority Date |
2012-02-13 (priority claim) |
| Patent Term |
20 years from filing (2033) |
| Legal status |
Active, maintained with annual fees |
| Similar patents |
China, US, Europe, other Latin American countries |
| Filing trends |
Growth in chemical compound patents (2010–2020) |
Implications for Industry
- The patent's scope offers protection for a specific chemical entity and its therapeutic use, limiting competitors from manufacturing identical compounds or formulations for the same indications.
- The landscape indicates ongoing innovation, making patent enforcement critical to maintain market exclusivity.
Key Takeaways
- MX2013003037 covers a specific chemical compound with claims centered on its structure and use in therapy.
- Claims are broad regarding indications but specific to chemically defined compounds.
- The patent landscape is active, with a focus on chemical entities for chronic diseases; legal robustness appears stable.
- Enforcement will depend on clear differentiation from prior art and maintaining patent rights through fee payments.
- The patent’s lifespan extends to 2033, with potential for renewal and legal challenges influencing commercial strategy.
FAQs
1. Is the patent MX2013003037 enforceable in Mexico?
Yes. It is active and has not been challenged or invalidated in recent filings.
2. Can a generic manufacturer produce a similar compound?
Only if they design around the claims or wait until patent expiry in 2033.
3. Does the patent cover formulations or only the chemical compound?
It covers both the compound and specific formulations, including dosages and administration routes.
4. How does the patent landscape affect market entry?
It restricts competitors from producing identical compounds or uses until 2033, barring licensing or legal challenges.
5. Are there patent challenges anticipated for this patent?
Potential exists, especially if prior art surfaces, but none are documented presently.
References
[1] IMPI. (2022). Patent law in Mexico: Pharmaceuticals.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] Mexican Patent Office. (2022). Patent examination guidelines.
[4] European Patent Office. (2022). Chemical patents: Trends and analysis.
[5] U.S. Patent and Trademark Office. (2022). Chemical patent law overview.
